Safilo Group S.p.A. (BIT:SFL)
Italy
· Delayed Price · Currency is EUR 1.892
+0.040 (2.16%)
At close: Dec 5, 2025
Safilo Group Revenue
Safilo Group had revenue of 537.63M EUR in the half year ending June 30, 2025, a decrease of -2.27%. This brings the company's revenue in the last twelve months to 998.89M, down -0.76% year-over-year. In the year 2024, Safilo Group had annual revenue of 993.22M, down -3.08%.
Revenue (ttm)
998.89M
Revenue Growth
-0.76%
P/S Ratio
0.78
Revenue / Employee
289.62K
Employees
3,645
Market Cap
783.74M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 993.22M | -31.51M | -3.08% |
| Dec 31, 2023 | 1.02B | -52.01M | -4.83% |
| Dec 31, 2022 | 1.08B | 107.16M | 11.05% |
| Dec 31, 2021 | 969.58M | 189.29M | 24.26% |
| Dec 31, 2020 | 780.30M | -158.74M | -16.90% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.55B |
| DiaSorin | 1.21B |
| Amplifon | 2.41B |
| EL.En. | 580.41M |
| Philogen | 84.66M |
| Pharmanutra | 127.15M |
| GPI S.p.A. | 531.42M |
| Garofalo Health Care | 483.61M |
Safilo Group News
- 4 weeks ago - Safilo Group S.p.A. (SAFLY) Q3 2025 Sales/ Trading Statement Call - Slideshow - Seeking Alpha
- 4 weeks ago - Safilo Group S.p.A. (SAFLY) Q3 2025 Sales Call Transcript - Seeking Alpha
- 7 months ago - Carrera Eyewear Unveils Exclusive Collaboration with Pat Cummins - Business Upturn
- 9 months ago - Safilo Group SpA (STU:S5U5) Q4 2024 Earnings Call Highlights: Resilience Amidst Challenges - GuruFocus